Cell and Gene Therapy Catapult Establishes Technology Advisory Board
-
By
February 19, 2026
-
2 min
1. CGT Catapult has established a Technology Advisory Board.2. The board aims to support advanced therapy adoption.3. Dr. Phil Vanek chairs the board, comprising industry experts.4. Key focus areas include data, manufacturing, and patient pathways.5. The initiative seeks to remove barriers for therapy access.6. Matthew Durdy emphasizes meeting industry innovation needs.7. The board will identify challenges and opportunities in therapy evolution.
Listen Tab content